Categories
- NEWS (5)
- BLOG (29)
- Technical Documentation (40)
MAIKONG.LTD, a global leader in the development and manufacturing of early diagnostic and treatment devices for diabetes, offers a range of advanced equipment, including the Neuropathy Screening and Detection Equipment, Digital Biothesiometer, and Near-Infrared Diabetic Treatment Devices. These tools play a crucial role in identifying and managing one of the most common and severe complications of diabetes—diabetic neuropathy.
Diabetic neuropathy affects up to 50% of people with diabetes and is characterized by damage to the peripheral nervous system, often leading to chronic pain, numbness, and severe complications like foot ulcers. This condition can significantly impact a patient’s quality of life, making early detection and effective treatment essential.
Diabetic neuropathy involves widespread pathological changes that can affect various parts of the nervous system, including the peripheral nerves, autonomic nerves, cranial nerves, and even the brain and spinal cord. Early signs of neuropathy include demyelination and axonal degeneration, with Schwann cell proliferation. As the disease progresses, axonal degeneration becomes more prominent, and the loss of myelin fibers is observed.
In some cases, clinical findings and electrophysiological tests may suggest chronic inflammatory demyelinating polyneuropathy (CIDP), which presents with inflammatory infiltration, demyelination, and axonal loss. It is often difficult to distinguish diabetic neuropathy from idiopathic CIDP. When the autonomic nervous system is involved, the degeneration of visceral and sympathetic ganglion cells is observed. Microvascular involvement is another common feature, including endothelial cell proliferation, thickening of the vascular walls, and reduced capillary numbers. This can lead to small vessel occlusion.
Diabetic neuropathy can be classified into several types based on its presentation. The most widely accepted classification is the one modified by Thomas, which organizes neuropathy into symmetric and focal/multifocal categories:
Sensory loss may make patients unaware of injuries like burns or cuts, particularly in the feet, which can lead to ulceration, infection, or even amputation in severe cases. Autonomic symptoms, such as reduced sweating, can exacerbate foot problems by causing dry, cracked skin, which is more prone to infection.
Early detection and intervention are crucial for managing diabetic neuropathy. MAIKONG.LTD provides specialized equipment such as the Neuropathy Screening and Detection Equipment and the Digital Biothesiometer to assess the extent of nerve damage. For treatment, Near-Infrared Diabetic Treatment Devices help in alleviating symptoms and slowing down the progression of neuropathy.
Treatment strategies include:
Diabetic neuropathy is a debilitating complication of diabetes that can significantly affect quality of life. Early diagnosis and tailored treatment are essential for managing this condition. MAIKONG.LTD is at the forefront of developing diagnostic and treatment equipment that helps healthcare providers worldwide offer better care for diabetes patients.
In addition to their cutting-edge devices, MAIKONG.LTD offers OEM/ODM services, providing customized solutions for packaging, design, and software with features such as a customizable startup logo. Through their innovative technology, MAIKONG.LTD is committed to improving the lives of individuals with diabetes and supporting the global healthcare community.